Generic:
Sitagliptin
Therapeutic Class:
DPP-IV Inh A-Diab Plain
Composition:
Each Glyzia tablet contains 50 or 100 mg of sitagliptin.
Description:
Glyzia tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase4 (DPP-4) enzyme
Indications:
Glyzia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The recommended dose of Glyzia is 100 mg once daily. Glyzia can be taken with or without food.
Presentation:Glyzia Tab 50 mg and 100 mg is available in pack of 14’s.